B. Devadas

发表

Substrate specificity of Saccharomyces cerevisiae myristoyl-CoA: protein N-myristoyltransferase. Analysis of fatty acid analogs containing carbonyl groups, nitrogen heteroatoms, and nitrogen heterocycles in an in vitro enzyme assay and subsequent identification of inhibitors of human immunodeficienc

D. Rudnick, A. Katoh, S. Adams, 1992, The Journal of biological chemistry.

N-myristoylation of Arf proteins in Candida albicans: an in vivo assay for evaluating antifungal inhibitors of myristoyl-CoA: protein N-myristoyltransferase.

J. Lodge, J. Gordon, C. Mcwherter, 1997, Microbiology.

Selective peptidic and peptidomimetic inhibitors of Candida albicans myristoylCoA: protein N-myristoyltransferase: a new approach to antifungal therapy.

J. Gordon, C. Mcwherter, D. Brown, 1997, Biopolymers.

4-oxatetradecanoic acid is fungicidal for Cryptococcus neoformans and inhibits replication of human immunodeficiency virus I.

J. Lodge, G. Gokel, C. A. Langner, 1992, The Journal of biological chemistry.

Titration calorimetric analysis of AcylCoA recognition by myristoylCoA:protein N-myristoyltransferase.

G. Gokel, J. Gordon, R. S. Bhatnagar, 1997, Biochemistry.

Incorporation of 12-methoxydodecanoate into the human immunodeficiency virus 1 gag polyprotein precursor inhibits its proteolytic processing and virus production in a chronically infected human lymphoid cell line.

J. Gordon, L. Ratner, R. Duronio, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Nucleosides from carbohydrate adducts of diaminomaleonitrile. A novel synthesis of 5-amino-1-(.beta.-D-ribofuranosyl)imidazole-4-carboxamide and 5-amino-1-(.beta.-D-ribopyranosyl)imidazole-4-carboxamide

J. Ferris, B. Devadas, Chunmin Huang, 1985 .

Functional analysis of protein N-myristoylation: metabolic labeling studies using three oxygen-substituted analogs of myristic acid and cultured mammalian cells provide evidence for protein-sequence-specific incorporation and analog-specific redistribution.

J. Gordon, R. Heuckeroth, J. Buss, 1990, Proceedings of the National Academy of Sciences of the United States of America.

The substrate specificity of Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase. Analysis of myristic acid analogs containing oxygen, sulfur, double bonds, triple bonds, and/or an aromatic residue.

J. Atwood, D. Rudnick, A. Katoh, 1991, The Journal of biological chemistry.

Design and syntheses of potent and selective dipeptide inhibitors of Candida albicans myristoyl-CoA:protein N-myristoyltransferase.

J. Gordon, C. Mcwherter, J. Sikorski, 1995, Journal of medicinal chemistry.

Novel biologically active nonpeptidic inhibitors of myristoylCoA:protein N-myristoyltransferase.

J. Lodge, J. Gordon, C. Mcwherter, 1998, Journal of medicinal chemistry.

Conformationally constrained [p-(omega-aminoalkyl)phenacetyl]-L-seryl-L-lysyl dipeptide amides as potent peptidomimetic inhibitors of Candida albicans and human myristoyl-CoA:protein N-myristoyl transferase.

J. Gordon, C. Mcwherter, D. Brown, 1997, Journal of medicinal chemistry.

Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.

J. Lodge, J. Gordon, D. W. Kuneman, 1997, Journal of medicinal chemistry.